Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST

NEXT STORY
Endeavour Increases 2021 Production Guidance by 50% to 1.4 – 1.5 Million Ounces
PREV STORY
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit

author_avatar
NASDAQ Market News

Harpoon Therapeutics Doses First Patient with HPN328, an Anti-DLL3 T Cell Engager for Treatment of Small Cell Lung Cancer and other DLL3-Associated Tumors

author_avatar
NASDAQ Market News

APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor

APEIRON strengthens its proprietary Cbl-b portfolio with cutting edge immunotherapy technology developed at IMBA ...

author_avatar
NASDAQ Market News